BioLife Solutions Inc (BLFS)

[techisbest]

BOTHELL, Wash., Oct. 30, 2017 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media, today announced the receipt of $1.9 million through the cash exercise of 393,070 common stock purchase warrants. Each warrant was exercised to purchase one share of common stock for $4.75 per share. The warrants were originally issued as part of a financing completed in March 2014, and were exercised by several unaffiliated holders over the past six weeks. No inducements or incentives were offered to the parties exercising the warrants.

Roderick de Greef, Chief Financial Officer, commented, "The $1.9 million of cash received from the exercise of these warrants enhances our balance sheet, when combined with the $2.3 million cash balance we reported at June 30, 2017."

https://finance.yahoo.com/news/biolife-solutions-receives-1-9-103000511.html